5% Topical Ibuprofen (IBU) for Ankle Sprain

• Status: Completed
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is being conducted to evaluate the effects of IBU 5% Topical Gel versus topical placebo for the relief of pain associated with a first or second degree ankle sprain. Both twice daily and three times daily regimens will be evaluated.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Ibuprofen

Criteria

Inclusion Criteria:

• First or second degree ankle sprain within 48 hours of first dose of study medication

• Medically cleared to participate

Exclusion Criteria:

• Similar injury of same joint within last 6 months

• Requires bed rest, surgery, or over-the-counter or prescription analgesics